A study comparing two minimally invasive procedures for managing benign prostatic hyperplasia found that urethral implants provided more durable symptom control than thermal therapy. The CLEAR RCT study included 68 men in the US and UK who underwent either UroLift or Rezūm. The UroLift procedure showed faster relief of symptoms, lower catheterization rates, and higher patient satisfaction at 1 month compared to Rezūm. However, longer follow-up is needed to determine the durability of symptom relief. Both procedures have low risk of erectile dysfunction and allow patients to resume routine activities within a few days. Patient and clinician preference will likely play a role in selecting the best treatment option.
Source link
BPH Trial Finds One Approach Clinically Superior
